Literature DB >> 14581568

Analysis of herpes simplex virus ICP0 promoter function in sensory neurons during acute infection, establishment of latency, and reactivation in vivo.

R L Thompson1, May T Shieh, N M Sawtell.   

Abstract

We have begun an analysis of the functional architecture of the ICP0 promoter in neurons in vivo with the ultimate goal of determining how this gene is regulated during reactivation in vivo. Promoter/reporter mutants in which the Escherichia coli beta-galactosidase (beta-Gal) gene was driven by various permutations of the ICP0 promoter were employed to permit the analysis of promoter function without the added complications that would arise due to inappropriate regulation of ICP0 protein levels. A whole-ganglion immunohistochemical staining procedure (N. M. Sawtell, J. Virol. 77:4127-4138, 2003) was used for direct comparisons of the expression of the promoter/reporter gene to expression of the native protein in the same cell. In this way, the expression of the putative wild-type promoter could be validated and results for mutant promoters could be compared to expression of the native gene. We found that a DNA fragment from bp -562 through the methionine start codon of the ICP0 gene contained all sequences required for properly regulated ICP0 expression in diverse cell types (including sensory neurons of the trigeminal ganglia [TG]) in vitro and in vivo, as indicated by colocalization of ICP0 and beta-Gal. Truncation of the ICP0 promoter to bp -145 or -129 resulted in the loss of immediate-early (alpha) kinetics. The truncated promoters expressed high levels of the reporter gene with leaky late (gamma1) kinetics in vitro and in some cell types in vivo. Unexpectedly, the truncated promoters did not express in TG neurons. Thus, TAATGARAT or other sequences upstream of bp -145 in the ICP0 promoter are required for basal expression of ICP0 in neurons but are not required for basal expression in other cells in vivo. There was a >95% concordance between reporter and native protein expression detected with the 562-bp promoter in neurons during the acute stage. However, this was not the case during reactivation from latency in vivo, as nearly twice as many neurons contained detectable beta-Gal as contained detectable ICP0. This same 562-bp promoter/reporter cassette, when placed in the context of a latency-associated transcript (LAT) null mutant, resulted in >95% concordance of expression of beta-Gal and ICP0 during reactivation in vivo. These last results strongly suggest that there is a posttranscriptional constraint on the expression of ICP0 protein during reactivation from latency and that this constraint is mediated by LAT.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14581568      PMCID: PMC254249          DOI: 10.1128/jvi.77.22.12319-12330.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  76 in total

1.  Herpes simplex virus neurovirulence and productive infection of neural cells is associated with a function which maps between 0.82 and 0.832 map units on the HSV genome.

Authors:  R L Thompson; S K Rogers; M A Zerhusen
Journal:  Virology       Date:  1989-10       Impact factor: 3.616

2.  Quantitative polymerase chain reaction analysis of herpes simplex virus DNA in ganglia of mice infected with replication-incompetent mutants.

Authors:  J P Katz; E T Bodin; D M Coen
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

3.  Host cell proteins bind to the cis-acting site required for virion-mediated induction of herpes simplex virus 1 alpha genes.

Authors:  T M Kristie; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

Review 4.  Regulation of herpes simplex virus gene expression.

Authors:  J P Weir
Journal:  Gene       Date:  2001-06-27       Impact factor: 3.688

Review 5.  Transcription of the herpes simplex virus genome during productive and latent infection.

Authors:  E K Wagner; J F Guzowski; J Singh
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1995

6.  Reactivation of latent herpes simplex virus by adenovirus recombinants encoding mutant IE-0 gene products.

Authors:  X X Zhu; J X Chen; C S Young; S Silverstein
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

7.  Biological characterization of a herpes simplex virus intertypic recombinant which is completely and specifically non-neurovirulent.

Authors:  R L Thompson; J G Stevens
Journal:  Virology       Date:  1983-11       Impact factor: 3.616

8.  Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early, and late genes in productively infected cells.

Authors:  W Cai; P A Schaffer
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

9.  A dynamic connection between centromeres and ND10 proteins.

Authors:  R D Everett; W C Earnshaw; A F Pluta; T Sternsdorf; A M Ainsztein; M Carmena; S Ruchaud; W L Hsu; A Orr
Journal:  J Cell Sci       Date:  1999-10       Impact factor: 5.285

10.  Pathogenicity of glycoprotein C negative mutants of herpes simplex virus type 1 for the mouse central nervous system.

Authors:  J C Sunstrum; C E Chrisp; M Levine; J C Glorioso
Journal:  Virus Res       Date:  1988-08       Impact factor: 3.303

View more
  18 in total

1.  HSV-1 gene expression from reactivated ganglia is disordered and concurrent with suppression of latency-associated transcript and miRNAs.

Authors:  Te Du; Guoying Zhou; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

2.  Therapeutic implications of new insights into the critical role of VP16 in initiating the earliest stages of HSV reactivation from latency.

Authors:  Richard L Thompson; Nancy M Sawtell
Journal:  Future Med Chem       Date:  2010-07       Impact factor: 3.808

3.  Evidence that the herpes simplex virus type 1 ICP0 protein does not initiate reactivation from latency in vivo.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

4.  The herpes simplex virus type 1 latency associated transcript locus is required for the maintenance of reactivation competent latent infections.

Authors:  Richard L Thompson; Nancy M Sawtell
Journal:  J Neurovirol       Date:  2011-12-30       Impact factor: 2.643

5.  Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression.

Authors:  Vilma Decman; Paul R Kinchington; Stephen A K Harvey; Robert L Hendricks
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  ICP0 is not required for efficient stress-induced reactivation of herpes simplex virus type 1 from cultured quiescently infected neuronal cells.

Authors:  Craig S Miller; Robert J Danaher; Robert J Jacob
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  Promyelocytic leukemia-nuclear body proteins: herpesvirus enemies, accomplices, or both?

Authors:  Ryan T Saffert; Robert F Kalejta
Journal:  Future Virol       Date:  2008-05-01       Impact factor: 1.831

8.  MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs.

Authors:  Jennifer Lin Umbach; Martha F Kramer; Igor Jurak; Heather W Karnowski; Donald M Coen; Bryan R Cullen
Journal:  Nature       Date:  2008-07-02       Impact factor: 49.962

9.  Herpes simplex virus type 1 latently infected neurons differentially express latency-associated and ICP0 transcripts.

Authors:  Séverine Maillet; Thierry Naas; Sophie Crepin; Anne-Marie Roque-Afonso; Florence Lafay; Stacey Efstathiou; Marc Labetoulle
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

10.  A historical analysis of herpes simplex virus promoter activation in vivo reveals distinct populations of latently infected neurones.

Authors:  João T Proença; Heather M Coleman; Viv Connor; Douglas J Winton; Stacey Efstathiou
Journal:  J Gen Virol       Date:  2008-12       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.